Sign In
Buy HRMY
$32.10
+1.19 (+3.85%)
At Close: Jun 03, 2026
HARMONY BIOSCIENCES TO PRESENT NEW WAKIX® (PITOLISANT) SAFETY AND EFFICACY DATA AT SLEEP 2023 ANNUAL MEETING
08:05am, Wednesday, 10'th May 2023
Late-breaking Phase 2 proof-of-concept study in Prader-Willi syndrome accepted for poster presentation PLYMOUTH MEETING, Pa. , May 10, 2023 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony
Harmony Biosciences Holdings, Inc. (HRMY) Q1 2023 Earnings Call Transcript
02:43pm, Tuesday, 02'nd May 2023
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY ) Q1 2023 Earnings Conference Call May 2, 2023 8:30 AM ET Company Participants Luis Sanay - Head, IR Jeffrey Dayno - President and CEO Jeffrey Dierks -
Harmony Biosciences Holdings, Inc. (HRMY) Surpasses Q1 Earnings and Revenue Estimates
10:40am, Tuesday, 02'nd May 2023
Harmony Biosciences Holdings, Inc. (HRMY) came out with quarterly earnings of $0.48 per share, beating the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.51 per share a y
HARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2023 FINANCIAL RESULTS ON MAY 2, 2023
08:05am, Thursday, 20'th Apr 2023
PLYMOUTH MEETING, Pa. , April 20, 2023 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercial
7 Stocks to Buy to Bag Big-Time Returns in Q2
02:01pm, Sunday, 16'th Apr 2023
If you're the type that runs toward danger, these stocks to buy may be right for you. To facilitate mobility, the enterprises on this list feature a market capitalization between $500 million to $2 bi
7 Biotech Stocks to Buy for 100% Returns
01:19pm, Sunday, 09'th Apr 2023
Generally speaking, biotech stocks to buy offer investors an excellent opportunity for significant upside success. According to Grand View Research, the global market size for the industry reached $1.
Harmony Biosciences Holdings, Inc. (HRMY) Soars 8.3%: Is Further Upside Left in the Stock?
05:21am, Thursday, 30'th Mar 2023
Harmony Biosciences Holdings, Inc. (HRMY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into
Why Shares of Harmony Bioscience Are Slumping Tuesday
02:17pm, Tuesday, 28'th Mar 2023
Harmony has only one approved therapy, Wakix, to treat excessive daytime sleepiness. The drug was responsible for all of the company's revenue in 2022.
HRMY Stock Alert: Scorpion Short Report Sends Harmony Plunging
01:03pm, Tuesday, 28'th Mar 2023
Shares of Harmony Biosciences (NASDAQ: HRMY ) stock are plunging lower by about 25% following a short report from Scorpion Capital. The activist short seller spent four months researching the report,
7 Healthcare Stocks to Buy for Long-Term Growth and Stability
04:13pm, Tuesday, 21'st Mar 2023
Stock market investors have been on a rollercoaster ride over the past year. The Federal Reserve continues to be hawkish in controlling inflation.
Harmony Biosciences: Why I Am Adding More Shares
07:16am, Sunday, 12'th Mar 2023
Today, we circle back on a biopharma name called Harmony Biosciences Holdings. The company recently posted solid fourth quarter results, and the stock seems undervalued after an approximate 30% declin
HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
08:05am, Monday, 06'th Mar 2023
PLYMOUTH MEETING, Pa. , March 6, 2023 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializ
Harmony Biosciences Holdings, Inc. (HRMY) Q4 Earnings and Revenues Beat Estimates
12:04am, Wednesday, 22'nd Feb 2023
Harmony Biosciences Holdings, Inc. (HRMY) delivered earnings and revenue surprises of 87.04% and 0.46%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead
Harmony Biosciences Holdings, Inc. (HRMY) Q4 2022 Earnings Call Transcript
02:32pm, Tuesday, 21'st Feb 2023
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY ) Q4 2022 Earnings Conference Call February 21, 2023 8:30 AM ET Company Participants Luis Sanay - Head-Investor Relations Jeffrey Dierks - Chief Commerc
Harmony Biosciences Holdings, Inc. (HRMY) Q4 Earnings and Revenues Beat Estimates
10:32am, Tuesday, 21'st Feb 2023
Harmony Biosciences Holdings, Inc. (HRMY) delivered earnings and revenue surprises of 87.04% and 0.46%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead
